BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34990422)

  • 1. Anal Adenocarcinoma: A Rare Entity in Need of Multidisciplinary Management.
    Lukovic J; Kim JJ; Liu ZA; Cummings BJ; Brierley JD; Wong RKS; Ringash JG; Dawson LA; Barry A; Krzyzanowska MK; Chen EX; Hedley DW; Quereshy FA; Swallow CJ; Gryfe RN; Kennedy ED; Easson AM; Hosni A
    Dis Colon Rectum; 2022 Feb; 65(2):189-197. PubMed ID: 34990422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
    Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
    Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative Management.
    Feferman Y; Rosen RY; Gebran S; Yuval JB; Kerioui M; Gönen M; Wei IH; Widmar M; Nash GM; Weiser MR; Paty PB; Hajj C; Roth O'Brien DA; Romesser PB; Crane CH; Smith JJ; Garcia Aguilar J; Pappou EP
    Dis Colon Rectum; 2024 Apr; 67(4):496-504. PubMed ID: 38127627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Cotti GC; Pandini RV; Braghiroli OFM; Nahas CSR; Bustamante-Lopez LA; Marques CFS; Imperiale AR; Ribeiro U; Salvajoli B; Hoff PM; Nahas SC
    Dis Colon Rectum; 2022 Mar; 65(3):333-339. PubMed ID: 34775415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Oncologic Outcomes of Adenocarcinoma of the Anal Canal in Patients With Crohn's Disease.
    Yasuhara M; Beppu N; Uchino M; Ikeuchi H; Matsuda I; Hirota S; Ikeda M; Tomita N
    Dis Colon Rectum; 2021 Apr; 64(4):409-419. PubMed ID: 33394780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Adjuvant Therapy Compliance and Anastomotic Leakage on the Oncologic Outcomes of Patients With Rectal Cancer After Curative Resection.
    Fang C; Nie P; Jing P; Zhang Y; Yang L; Yu Y; Wang C; Zhou Z
    Dis Colon Rectum; 2021 Jun; 64(6):689-696. PubMed ID: 33394777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Implication of Perineural and Lymphovascular Invasion in Rectal Cancer Patients Who Underwent Surgery After Preoperative Chemoradiotherapy.
    Kim YI; Kim CW; Kim JH; Kim J; Ro JS; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
    Dis Colon Rectum; 2022 Nov; 65(11):1325-1334. PubMed ID: 34856592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
    Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
    Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
    Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
    Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
    Antunez AG; Kanters AE; Regenbogen SE
    Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Colorectal Lymphoma: Institutional Experience and Review of a National Database.
    Hangge PT; Calderon E; Habermann EB; Glasgow AE; Mishra N
    Dis Colon Rectum; 2019 Oct; 62(10):1167-1176. PubMed ID: 30489325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Neoadjuvant Therapy Significantly Increases Complete Clinical Response.
    Rettig RL; Beard BW; Ryoo JJ; Kulkarni S; Gulati M; Tam M; Attaluri V
    Dis Colon Rectum; 2023 Mar; 66(3):374-382. PubMed ID: 35239525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateral Pelvic Nodal Management and Patterns of Failure in Patients Receiving Short-Course Radiation for Locally Advanced Rectal Cancer.
    Hassanzadeh C; Mirza K; Kalaghchi B; Fallahian F; Chin RI; Roy A; Stowe H; Low G; Pedersen K; Wise P; Glasgow S; Roach M; Henke L; Badiyan S; Mutch M; Kim H
    Dis Colon Rectum; 2024 Jan; 67(1):54-61. PubMed ID: 37787502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer.
    Chin RI; Schiff JP; Shetty AS; Pedersen KS; Aranha O; Huang Y; Hunt SR; Glasgow SC; Tan BR; Wise PE; Silviera ML; Smith RK; Suresh R; Byrnes K; Samson PP; Badiyan SN; Henke LE; Mutch MG; Kim H
    Dis Colon Rectum; 2023 Jul; 66(7):973-982. PubMed ID: 36876988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Size Criteria for Lateral Lymph Node Dissection After Neoadjuvant Chemoradiotherapy for Rectal Cancer.
    Kawai K; Shiratori H; Hata K; Nozawa H; Tanaka T; Nishikawa T; Murono K; Ishihara S
    Dis Colon Rectum; 2021 Mar; 64(3):274-283. PubMed ID: 33395141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Role for Primary Tumor Location in Patients With Colorectal Liver Metastases: A Comparison of Right-Sided Colon, Left-Sided Colon, and Rectum.
    Takamizawa Y; Shida D; Horie T; Tsukamoto S; Esaki M; Shimada K; Kondo T; Kanemitsu Y
    Dis Colon Rectum; 2023 Feb; 66(2):233-242. PubMed ID: 35714342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitive Chemoradiation for Rectal Cancer: Is There a Role for Dose Escalation? A National Cancer Database Study.
    Wegner RE; Hasan S; Renz PB; Raj MS; Monga DK; Finley GG; Kirichenko AV; McCormick JT
    Dis Colon Rectum; 2019 Nov; 62(11):1336-1343. PubMed ID: 31567930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.
    Elshami M; Goldstone RN; Blaszkowsky LS; Cusack JC; Hong TS; Wo JY; Qadan M
    Dis Colon Rectum; 2022 Oct; 65(10):1224-1231. PubMed ID: 35714358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database.
    Fernandez LM; São Julião GP; Renehan AG; Beets GL; Papoila AL; Vailati BB; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Figueiredo NL; Van De Velde CJH; Habr-Gama A; Perez RO;
    Dis Colon Rectum; 2023 Jan; 66(1):41-49. PubMed ID: 36515514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation Between the Distance to Mesorectal Fascia and Prognosis of cT3 Rectal Cancer: Results of a Multicenter Study From China.
    Zhang XY; Li XT; Shi YJ; Lu QY; Cao W; Zhang HM; Wang L; Zhu HT; Yu T; Guan Z; Sun RJ; Zhu HB; Wu AW; Sun YS
    Dis Colon Rectum; 2022 Mar; 65(3):322-332. PubMed ID: 34459446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.